Sanofi launches new once-daily oral treatment for RRMS

Since 2005, ten clinical trials involving more than 4000 patients have been conducted. Since then, Aubagio has been approved for

The efficacy and benefits of GLP-1 and basal insulin

According to the International Diabetes Federation, it is estimated that an average of 387 million people worldwide live with diabetes,

Newsletter Sign Up

Be the first to receive email updates on all things CPD, keep abreast of latest industry revelations, and keep adding to your CPD point score.

Newsletter Sign up - Other Pages